BioLineRx (BLRX) Institutional Ownership $0.55 +0.01 (+1.87%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$738.61KNumber ofInstitutional Sellers(last 12 months)0 Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/1/2024 Atria Investments Inc133,974$72K0.0%+27.9%0.168% 8/22/2024PVG Asset Management Corp123,580$70K0.3%N/A0.155% 8/15/2024CVI Holdings LLC815,683$462K0.4%N/A1.020% 3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024 NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 11/21/2023 Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023 Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023 Values First Advisors Inc.48,348$88K0.1%N/A0.079% 10/11/2023 Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023 Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022 Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022 Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022 Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022 Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022 Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022 Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022 Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022 ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021 Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021 Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021 Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021 Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021 Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021 Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021 Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021 First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021 Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021 Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021 Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021 Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021 Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% 4/28/2021 Game Plan Financial Advisors LLC26,000$74K0.0%N/A0.061% Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now.2/12/2021 LPL Financial LLC42,876$108K0.0%+154.1%0.111% 2/10/2021 Rhumbline Advisers14,208$36K0.0%N/A0.037% 1/4/2021 Thomasville National Bank20,325$51K0.0%+62.6%0.089% 11/13/2020 Morgan Stanley768,335$1.26M0.0%+36.0%3.796% (Data available from 1/1/2016 forward) BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 10 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were Altium Capital Management LP ($2.02M), CVI Holdings LLC ($462K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), Atria Investments Inc ($72K), Rathbones Group PLC ($72K), and PVG Asset Management Corp ($70K).Learn more on BLRX's institutional investors. What percentage of BioLineRx stock is owned by institutional investors? 1.56% of BioLineRx stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx stock? Of the 9 institutional investors that purchased BioLineRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CVI Holdings LLC ($815.68K), PVG Asset Management Corp ($185.42K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), Atria Investments Inc ($29.19K), Allen Mooney & Barnes Investment Advisors LLC ($25K), and NorthRock Partners LLC ($17.13K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 1,187,589 shares in the last 24 months. This purchase volume represents approximately $930.02K in transactions. Which BioLineRx major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: Altium Capital Management LP ($823.98K), and PVG Asset Management Corp ($66.89K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 890,863 shares in the last 24 months. This volume of shares sold represents approximately $837.14K in transactions. Related Companies GALT Institutional Ownership DMAC Institutional Ownership TIL Institutional Ownership MDWD Institutional Ownership ADAP Institutional Ownership LFVN Institutional Ownership ACTU Institutional Ownership TSVT Institutional Ownership FULC Institutional Ownership GOSS Institutional Ownership This page (NASDAQ:BLRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
